[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP20070579T3 - Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use - Google Patents

Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use

Info

Publication number
HRP20070579T3
HRP20070579T3 HR20070579T HRP20070579T HRP20070579T3 HR P20070579 T3 HRP20070579 T3 HR P20070579T3 HR 20070579 T HR20070579 T HR 20070579T HR P20070579 T HRP20070579 T HR P20070579T HR P20070579 T3 HRP20070579 T3 HR P20070579T3
Authority
HR
Croatia
Prior art keywords
wort
john
pharmaceutical compositions
hypericum perforatum
usnea barbata
Prior art date
Application number
HR20070579T
Other languages
English (en)
Croatian (hr)
Inventor
Schempp Christoph
Jocher Andrea
Engel Kathrin
Huyke Constance
Original Assignee
Universittsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universittsklinikum Freiburg filed Critical Universittsklinikum Freiburg
Publication of HRP20070579T3 publication Critical patent/HRP20070579T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/09—Lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20070579T 2004-04-19 2007-12-24 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use HRP20070579T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04009213A EP1591125A1 (de) 2004-04-19 2004-04-19 Pharmazeutische Zusammensetzung enthaltend Extrakte aus Flechten und Johanniskraut
PCT/EP2005/003657 WO2005099728A1 (de) 2004-04-19 2005-04-07 Pharmazeutische zusammensetzungen aus bartflechten (usnea barbata) und johanniskraut (hypericum perforatum) sowie ihre verwendung

Publications (1)

Publication Number Publication Date
HRP20070579T3 true HRP20070579T3 (en) 2008-01-31

Family

ID=34924650

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070579T HRP20070579T3 (en) 2004-04-19 2007-12-24 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use

Country Status (13)

Country Link
US (1) US7687083B2 (xx)
EP (2) EP1591125A1 (xx)
AT (1) ATE376427T1 (xx)
CA (1) CA2563870C (xx)
DE (1) DE502005001791D1 (xx)
ES (1) ES2294697T3 (xx)
HR (1) HRP20070579T3 (xx)
ME (1) MEP3708A (xx)
PL (1) PL1755630T3 (xx)
RS (1) RS50550B (xx)
RU (1) RU2358750C2 (xx)
SI (1) SI1755630T1 (xx)
WO (1) WO2005099728A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105534978A (zh) * 2009-06-30 2016-05-04 德安生医有限公司 用于治疗红斑痤疮或红脸相关皮肤病的含黄连素或其类似物的组合物
GB0919210D0 (en) * 2009-11-03 2009-12-16 Syntopix Ltd Formulations
GB201021745D0 (en) * 2010-12-22 2011-02-02 Syntopix Group Plc Formulations
CN102949298A (zh) * 2011-12-20 2013-03-06 上海莱博生物科技有限公司 松萝酸和/或其盐的应用
RS54162B1 (en) * 2011-12-28 2015-12-31 Univerzitet U Beogradu PHARMACEUTICAL COMPOSITION BASED ON MEDICINAL HERBS FOR HUMAN AND VETERINARY MEDICINAL PRODUCTS
RU2582978C2 (ru) * 2014-01-14 2016-04-27 Федеральное государственное бюджетное учреждение науки Институт экологических проблем Севера Уральского отделения Российской академии наук СПОСОБ ПОЛУЧЕНИЯ ТВЕРДОГО ЭКСТРАКТА, ОБОГАЩЕННОГО УСНИНОВОЙ КИСЛОТОЙ, ИЗ СЛОЕВИЩ ЛИШАЙНИКА РОДА "Cladonia"
CN105076246A (zh) * 2015-08-28 2015-11-25 无限极（中国）有限公司 一种抗菌中药组合物及其制备方法、应用
EP3558374A4 (en) * 2016-12-23 2020-08-12 Klox Technologies Inc. BIOPHOTONIC COMPOSITIONS CONSISTING OF LICHEN EXTRACT AND THEIR USE IN THE TREATMENT OF SKIN DISORDERS
CN106943341B (zh) * 2017-05-10 2020-01-24 重庆理工大学 一种改善松萝酸透皮吸收的外用制剂及其在促皮肤创伤愈合中的应用
EP3654927B1 (en) * 2017-07-19 2023-09-06 Colgate-Palmolive Company Personal care compositions comprising zinc:usnic acid complexes and methods of use
CN108938509B (zh) * 2018-10-16 2021-06-18 头皮医生健康管理(中国)有限公司 去屑止痒组合物及其制备方法和其应用
PH12022552346A1 (en) * 2020-03-23 2023-11-29 Kerecis Ag Antimicrobial solutions and methods of using the same in the treatment or prevention of infections
IT202000008536A1 (it) 2020-04-21 2021-10-21 Pellegrino Masiello Composizione e metodo per il trattamento delle fasi intermedie della covid-19 e simili patologie virali con risposta infiammatoria sistemica
CN113876645B (zh) * 2020-07-01 2024-01-05 伽蓝（集团）股份有限公司 一种须松萝提取物及其应用和含其的皮肤外用剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05246876A (ja) * 1992-03-07 1993-09-24 Nippon Paint Co Ltd 抗菌剤
JPH0818956B2 (ja) * 1993-06-14 1996-02-28 花王株式会社 養毛・育毛料
DE10131641A1 (de) * 2000-12-22 2002-06-27 Schwabe Willmar Gmbh & Co Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions

Also Published As

Publication number Publication date
ES2294697T3 (es) 2008-04-01
PL1755630T3 (pl) 2008-03-31
MEP3708A (en) 2010-06-10
EP1755630B1 (de) 2007-10-24
RU2006140864A (ru) 2008-05-27
RU2358750C2 (ru) 2009-06-20
CA2563870C (en) 2013-02-19
WO2005099728A1 (de) 2005-10-27
EP1591125A1 (de) 2005-11-02
ATE376427T1 (de) 2007-11-15
US20080233145A1 (en) 2008-09-25
US7687083B2 (en) 2010-03-30
SI1755630T1 (sl) 2008-02-29
RS50550B (sr) 2010-05-07
CA2563870A1 (en) 2005-10-27
EP1755630A1 (de) 2007-02-28
DE502005001791D1 (de) 2007-12-06

Similar Documents

Publication Publication Date Title
HRP20070579T3 (en) Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use
MX2007010771A (es) Anfifilos peptidicos para union a heparina angiogenicos.
SE0301653D0 (sv) Novel compounds
EP2081957A4 (en) PEG-MODIFIED EXENDIN OR EXENDINANALOGONE AND COMPOSITIONS AND APPLICATION THEREOF
AR050353A1 (es) Composicion de anticuerpo her2
DE60318237D1 (de) Pharmazeutische zusammensetzungen enthaltend flavonoide und menthol
BRPI0510175A (pt) composições farmacêuticas comprimidas
WO2006089114A3 (en) Methods and compositions for treating an anthrax toxin mediated condition
ATE500835T1 (de) Entzündungshemmende zusammensetzungen und anwendungsverfahren
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
EP1701731A4 (en) GLP-1 (9-36) METHOD AND COMPOSITIONS
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
CL2007001748A1 (es) Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras.
WO2010099542A3 (en) Formulations of atp and analogas of atp
AT8372U2 (de) Desmopressin umfassende zusammensetzung
DE602005019416D1 (de) Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
AR030140A1 (es) Composiciones derivadas de la 2-piridinamina y metodos relacionados
NO20065791L (no) Asyklovir-formuleringer
WO2006058731A3 (de) Strahlungshärtbare beschichtungsmassen
DK1922128T3 (da) Element til reduktion af indholdet af finstøv i luften ved anvendelse af mos og/eller lav
HUP0400976A2 (hu) VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek
FR2872165B1 (fr) Nouveaux derives de pyrimido-benzimidazole
ATE535251T1 (de) Stabile wässrige g-csf-haltige zusammensetzungen
MXPA05008902A (es) Soluciones de drogas en mentol.
DK1824504T3 (da) Anti-tumor-kombinationer, der indeholder VEGF-trap og 5-fluoruracil eller et derivat deraf